Morgan Stanley’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,600
| Closed | -$25.4K | – | 7750 |
|
2023
Q2 | $25.4K | Sell |
6,600
-9,526
| -59% | -$36.7K | ﹤0.01% | 6484 |
|
2023
Q1 | $48.7K | Buy |
16,126
+5,566
| +53% | +$16.8K | ﹤0.01% | 6297 |
|
2022
Q4 | $21.6K | Sell |
10,560
-1,512
| -13% | -$3.1K | ﹤0.01% | 6660 |
|
2022
Q3 | $42K | Buy |
12,072
+1,043
| +9% | +$3.63K | ﹤0.01% | 6485 |
|
2022
Q2 | $46K | Sell |
11,029
-11,812
| -52% | -$49.3K | ﹤0.01% | 6656 |
|
2022
Q1 | $69K | Buy |
22,841
+9,579
| +72% | +$28.9K | ﹤0.01% | 6538 |
|
2021
Q4 | $62K | Sell |
13,262
-14,892
| -53% | -$69.6K | ﹤0.01% | 6710 |
|
2021
Q3 | $217K | Sell |
28,154
-47,233
| -63% | -$364K | ﹤0.01% | 5961 |
|
2021
Q2 | $648K | Buy |
75,387
+67,984
| +918% | +$584K | ﹤0.01% | 5360 |
|
2021
Q1 | $84K | Buy |
+7,403
| New | +$84K | ﹤0.01% | 6104 |
|